Enlivex Therapeutics Stock Price on December 26, 2024
| ENLV Stock | USD 1.25 0.02 1.63% |
Below is the normalized historical share price chart for Enlivex Therapeutics extending back to July 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Enlivex Therapeutics stands at 1.25, as last reported on the 27th of December, with the highest price reaching 1.25 and the lowest price hitting 1.22 during the day.
If you're considering investing in Enlivex Stock, it is important to understand the factors that can impact its price. Enlivex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0675, which denotes the company had a -0.0675% return per unit of risk over the last 3 months. Enlivex Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enlivex Therapeutics' Variance of 26.56, standard deviation of 5.15, and Mean Deviation of 3.48 to check the risk estimate we provide.
At this time, Enlivex Therapeutics' Common Stock is fairly stable compared to the past year. Preferred Stock Total Equity is likely to climb to about 10.2 M in 2024, whereas Treasury Stock is likely to drop (959.2 K) in 2024. . Price To Sales Ratio is likely to drop to 39.01 in 2024. Price Earnings Ratio is likely to drop to -1.81 in 2024. Enlivex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of December 1995 | 200 Day MA 1.6426 | 50 Day MA 1.2594 | Beta 1.105 |
Enlivex |
Sharpe Ratio = -0.0675
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ENLV |
Estimated Market Risk
| 5.17 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Enlivex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enlivex Therapeutics by adding Enlivex Therapeutics to a well-diversified portfolio.
Price Book 1.0173 | Book Value 1.618 | Enterprise Value 3.3 M | Enterprise Value Ebitda (1.49) | Shares Float 15.6 M |
Related Headline
Keros Therapeutics Headline on 26th of December 2024
Truist Financial Cuts Keros Therapeutics Price Target to 43.... by thelincolnianonline.com
Keros Therapeutics had its price objective cut by Truist Financial from 100.00 to 43.00 in a research report report published on Monday morning,Benzinga reports. They currently have a buy rating on the stock. Other equities research analysts have also issued research reports about the stock. Scotiabank dropped their target price on
Enlivex Therapeutics Valuation on December 26, 2024
It is possible to determine the worth of Enlivex Therapeutics on a given historical date. On December 26, 2024 Enlivex was worth 1.23 at the beginning of the trading date compared to the closed value of 1.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Enlivex Therapeutics stock. Still, in general, we apply an absolute valuation method to find Enlivex Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enlivex Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Enlivex Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.23 | 1.25 | 1.21 | 1.23 | 44,753 | |
12/26/2024 | 1.23 | 1.25 | 1.22 | 1.25 | 102,317 |
| Backtest Enlivex Therapeutics | | | Enlivex Therapeutics History | | | Enlivex Therapeutics Valuation | Previous |
Enlivex Therapeutics Trading Date Momentum on December 26, 2024
| On December 26 2024 Enlivex Therapeutics was traded for 1.25 at the closing time. The top price for the day was 1.25 and the lowest listed price was 1.22 . The trading volume for the day was 102.3 K. The trading history from December 26, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.60% . |
Enlivex Therapeutics Fundamentals Correlations and Trends
By evaluating Enlivex Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Enlivex Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Enlivex financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Enlivex Therapeutics Stock history
Enlivex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enlivex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enlivex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enlivex Therapeutics stock prices may prove useful in developing a viable investing in Enlivex Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 18.6 M | 19.5 M | |
| Net Loss | -28 M | -26.6 M |
Enlivex Therapeutics Quarterly Net Working Capital |
|
Enlivex Therapeutics Stock Technical Analysis
Enlivex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Enlivex Therapeutics Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Enlivex Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Enlivex Therapeutics December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Enlivex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enlivex Therapeutics shares will generate the highest return on investment. By undertsting and applying Enlivex Therapeutics stock market strength indicators, traders can identify Enlivex Therapeutics entry and exit signals to maximize returns
Enlivex Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Enlivex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Enlivex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enlivex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Enlivex Stock Analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.